We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current INVO market cap is 2.26M. The company's latest EPS is USD -3.2468 and P/E is -0.28.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 278k | 348k | 316k | 975k | 1.38M |
| Operating Income | -2.72M | -2.33M | -2.06M | -894k | -1.51M |
| Net Income | -2.77M | -2.55M | -2.24M | -1.25M | -2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.48M | 1.04M | 4.16M | 822k | 3.02M |
| Operating Income | -1.79M | -5.52M | -5.22M | -10.63M | -6.77M |
| Net Income | -2.17M | -8.35M | -6.66M | -10.89M | -8.04M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.1M | 6.15M | 6.64M | 19.48M | 20.89M |
| Total Liabilities | 5.08M | 6.06M | 8.34M | 19.1M | 20M |
| Total Equity | -978k | 88k | -1.71M | 373k | 893k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.8M | 10.95M | 10.47M | 4.1M | 20.89M |
| Total Liabilities | 5.51M | 5.2M | 3.16M | 5.08M | 20M |
| Total Equity | -3.71M | 5.74M | 7.31M | -978k | 893k |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.6M | -1.15M | -2.79M | -4.04M | -4.76M |
| Investing | -81k | -8k | -270k | -2.53M | -2.49M |
| Financing | 1.09M | 3.26M | 3.09M | 7.53M | 7.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.37M | -4.78M | -6.03M | -6.6M | -4.76M |
| Investing | -115k | -187k | -2.15M | -81k | -2.49M |
| Financing | -230k | 13.82M | 3.77M | 1.09M | 7.39M |
| Market Cap | 2.26M |
| Price to Earnings Ratio | -0.28 |
| Price to Sales Ratio | 0.75 |
| Price to Cash Ratio | 9.71 |
| Price to Book Ratio | 2.52 |
| Dividend Yield | - |
| Shares Outstanding | 2.47M |
| Average Volume (1 week) | 154.03k |
| Average Volume (1 Month) | 12.02M |
| 52 Week Change | -85.31% |
| 52 Week High | 8.60 |
| 52 Week Low | 0.50 |
| Spread (Intraday) | 0.02 (2.17%) |
| Company Name | INVO BioScience Inc |
| Address |
187 e warm springs road las vegas, nevada 89119 |
| Website | https://www.invobioscience.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
